Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify specific DNA sequences in real time. These instruments track DNA accumulation during each amplification cycle through fluorescent signals, enabling researchers to measure DNA amounts with high sensitivity and precision. They are vital tools in molecular biology, diagnostics, and research for applications including gene expression analysis, pathogen detection, and genetic variation studies.
The main product types of quantitative polymerase chain reaction (qPCR) instruments include quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems are laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. These systems include models such as the 7500, ViiA 7 Dx, Cobas 4800, CFX96, SmartCycler, GeneXpert, Rotor-Gene Q, Rotor-Gene Q 5plex HRM System, BioFire FilmArray systems, and others. They are applied in various fields like gene expression analysis, genotyping, pathogen detection, and diagnostics, and are utilized by end users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The quantitative polymerase chain reaction (qPCR) instruments market research report is one of a series of new reports from The Business Research Company that provides quantitative polymerase chain reaction (qPCR) instruments market statistics, including the quantitative polymerase chain reaction (qPCR) instruments industry's global market size, regional shares, competitors with the quantitative polymerase chain reaction (qPCR) instruments market share, detailed quantitative polymerase chain reaction (qPCR) instruments market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative polymerase chain reaction (qPCR) instruments market. This quantitative polymerase chain reaction (qPCR) instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The quantitative polymerase chain reaction (qPCR) instruments market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the increasing burden of chronic diseases, expanding applications in genetic and genomic research, rising public and private investments in life sciences, growing popularity of point-of-care diagnostics, and heightened demand for high-throughput testing systems.
The quantitative polymerase chain reaction (qPCR) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the increasing prevalence of infectious diseases, rising demand for personalized medicine, expanding use of qPCR in oncology, growing adoption of qPCR in clinical laboratories, and heightened focus on early disease detection. Major trends in the forecast period include technological advancements in qPCR platforms, integration of automation technologies, progress in microfluidics, development of multiplex qPCR technologies, and incorporation of cloud-based data management systems.
The rising incidence of infectious diseases is expected to drive the growth of the quantitative polymerase chain reaction (qPCR) instruments market in the future. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The increase in infectious diseases is largely due to the growth in global travel, which accelerates the spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments assist in combating infectious diseases by providing rapid, sensitive, and precise detection of pathogens, enabling timely diagnosis and effective management of diseases. For example, in February 2024, GOV.UK, a UK government department, reported that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Hence, the growing incidence of infectious diseases is propelling the expansion of the qPCR instruments market.
Key players in the quantitative polymerase chain reaction (qPCR) instruments market are focusing on developing advanced technologies, such as next-generation qPCR platforms, to improve testing accuracy, enhance workflow efficiency, and strengthen their competitive position in diagnostics. Next-generation qPCR platforms are advanced molecular diagnostic systems designed to offer greater sensitivity, faster processing, expanded multiplexing capabilities, and increased automation for superior testing performance and precision. For instance, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System, which provides next-generation qPCR functionalities with enhanced speed, accuracy, and automation. It delivers reliable, flexible, and efficient real-time PCR results for clinical and research applications and features advanced multiplexing, user-friendly software, and precise temperature control for consistent outcomes. Its advantages include quick adaptation to changing testing needs, optimized workflows with simplified data handling, and an improved user interface featuring a large touchscreen and seamless system integration.
In April 2023, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, formed a partnership with ALPCO-GeneProof to broaden access to PCR diagnostic solutions. Through this collaboration, Thermo Fisher aims to expand its molecular diagnostics portfolio by increasing its CE-IVD assay offerings and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics firm specializing in both molecular and immunodiagnostic solutions.
Major players in the quantitative polymerase chain reaction (qpcr) instruments market are F. Hoffmann-La Roche AG., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf SE, Cepheid Inc., Takara Bio Inc., bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc., Hangzhou Bioer Technology Co. Ltd., BioTeke Corporation, GeneReach Biotechnology Corp., Anitoa Systems LLC, Blue-Ray Biotech Corp., Chai Biotechnologies, Bio Molecular Systems Pty Ltd., Azure Biosystems Inc.
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantitative polymerase chain reaction (qPCR) instruments report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the quantitative polymerase chain reaction (qPCR) instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Quantitative Polymerase Chain Reaction (qPCR) Instruments Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on quantitative polymerase chain reaction (qpcr) instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for quantitative polymerase chain reaction (qpcr) instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantitative polymerase chain reaction (qpcr) instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Quantitative Polymerase Chain Reaction Systems; Reagents And Consumables; Software
2) By Instrument: 7500; Viia 7 Dx; Cobas 4800; Cfx96; Smartcycler; Genexpert; Rotor-Gene Q; Rotor-Gene Q 5plex Hrm System; Biofire Filmarray Systems; Other Instruments
3) By Application: Gene Expression; Genotyping; Pathogen Detection; Diagnostics; Other Applications
4) By End-Users: Diagnostic Laboratories; Hospitals And Clinics; Pharma And Biotech Companies; Other End-Users
Subsegments:
1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems; Portable Or Compact qPCR Devices; Digital Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Master Mixes; Buffers And Enzymes; Primers
3) By Software: Data Analysis Software; Cloud-Based Analytics Platforms; Instrument Control Software
Companies Mentioned: F. Hoffmann-La Roche AG.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Eppendorf SE; Cepheid Inc.; Takara Bio Inc.; bioMerieux SA; Analytik Jena GmbH; Standard BioTools Inc.; Hangzhou Bioer Technology Co. Ltd.; BioTeke Corporation; GeneReach Biotechnology Corp.; Anitoa Systems LLC; Blue-Ray Biotech Corp.; Chai Biotechnologies; Bio Molecular Systems Pty Ltd.; Azure Biosystems Inc.
4. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Growth Analysis And Strategic Analysis Framework
5.1. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative Polymerase Chain Reaction Systems
Reagents And Consumables
Software
6.2. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Segmentation By Instrument, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7500
Viia 7 Dx
Cobas 4800
Cfx96
Smartcycler
Genexpert
Rotor-Gene Q
Rotor-Gene Q 5plex Hrm System
Biofire Filmarray Systems
Other Instruments
6.3. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Expression
Genotyping
Pathogen Detection
Diagnostics
Other Applications
6.4. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Laboratories
Hospitals And Clinics
Pharma And Biotech Companies
Other End-Users
6.5. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Sub-Segmentation Of Quantitative Polymerase Chain Reaction (qPCR) Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction Systems
Portable Or Compact qPCR Devices
Digital Polymerase Chain Reaction Systems
6.6. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Master Mixes
Buffers And Enzymes
Primers
6.7. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Cloud-Based Analytics Platforms
Instrument Control Software
7. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Regional And Country Analysis
7.1. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion